IST:MEDTR's Days Payable is ranked better than 51.82% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 68.07
vs IST:MEDTR: 71.67
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEDITERA TIBBI MALZEMENAYI VE TICARET AS Days Payable Chart
MEDITERA TIBBI MALZEMENAYI VE TICARET AS Annual Data
IST:MEDTR vs ABT, SYK, MDT: Days Payable Comparison
For the Medical Devices subindustry, MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MEDITERA TIBBI MALZEMENAYI VE TICARET AS Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Days Payable distribution charts can be found below:
* The bar in red indicates where MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Days Payable falls into.
MEDITERA TIBBI MALZEMENAYI VE TICARET AS Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEDITERA TIBBI MALZEMENAYI VE TICARET AS (IST:MEDTR) has a Days Payable of 82.50 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on MEDITERA TIBBI MALZEMENAYI VE TICARET AS and its competitors. This is near median its historical median of 82.72. Over the past decade, MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Days Payable has ranged from 49.23 to 107.56. According to the industry distribution chart, MEDITERA TIBBI MALZEMENAYI VE TICARET AS ranks #383 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 48.2%.
Is MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Days Payable too high?
MEDITERA TIBBI MALZEMENAYI VE TICARET AS's current Days Payable of 82.50 is near median its 10-year median of 82.72. Over the past 10 years, this metric has ranged from a low of 49.23 to a high of 107.56. The Medical Devices & Instruments industry median Days Payable is 68.07. MEDITERA TIBBI MALZEMENAYI VE TICARET AS's value of 82.50 is 21.2% above this industry median. Based on the distribution chart, MEDITERA TIBBI MALZEMENAYI VE TICARET AS ranks #383 out of 795 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, MEDITERA TIBBI MALZEMENAYI VE TICARET AS has a GF Score™ of 79/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, MEDITERA TIBBI MALZEMENAYI VE TICARET AS ranks #383 out of 795 companies for Days Payable. This puts MEDITERA TIBBI MALZEMENAYI VE TICARET AS in the upper half of its industry. The industry median Days Payable is 68.07. MEDITERA TIBBI MALZEMENAYI VE TICARET AS's value of 82.50 is 21.2% above this benchmark. Historically, MEDITERA TIBBI MALZEMENAYI VE TICARET AS's own Days Payable has ranged from 49.23 to 107.56 over the past decade. While the company's 10-year median is 82.72 vs. the industry median of 68.07, MEDITERA TIBBI MALZEMENAYI VE TICARET AS has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.07, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MEDITERA TIBBI MALZEMENAYI VE TICARET AS's current Days Payable of 82.50 is 21.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on MEDITERA TIBBI MALZEMENAYI VE TICARET AS and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MEDITERA TIBBI MALZEMENAYI VE TICARET AS's current Days Payable is 82.50, which is near median its own 10-year median of 82.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MEDITERA TIBBI MALZEMENAYI VE TICARET AS stock overvalued right now?
Based on GuruFocus' analysis, MEDITERA TIBBI MALZEMENAYI VE TICARET AS (IST:MEDTR) is currently considered Significantly Undervalued. The stock's GF Value™ is ₺43.61, compared to a current price of ₺28.86 — trading 33.8% below its estimated fair value. The current Days Payable is 82.50, which is near median its 10-year median of 82.72 and 21.2% above the Medical Devices & Instruments industry median of 68.07. MEDITERA TIBBI MALZEMENAYI VE TICARET AS's overall GF Score™ is 79/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For MEDITERA TIBBI MALZEMENAYI VE TICARET AS (IST:MEDTR), the current Days Payable is 82.50 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MEDITERA TIBBI MALZEMENAYI VE TICARET AS (IST:MEDTR) Overvalued in 2026?
Based on GuruFocus' analysis, MEDITERA TIBBI MALZEMENAYI VE TICARET AS stock appears to be undervalued.
The current stock price of ₺28.86 is trading 33.8% below its estimated GF Value™ of ₺43.61.
GuruFocus considers MEDITERA TIBBI MALZEMENAYI VE TICARET AS to be Significantly Undervalued.
Key valuation signals for IST:MEDTR:
Days Payable: 82.50 (near median its 10-year median of 82.72)
GF Value™: ₺43.61 vs. price of ₺28.86 (33.8% below fair value)
Industry Position: 21.2% above the Medical Devices & Instruments median (#383 of 795)
No single metric tells the full story. See the IST:MEDTR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MEDITERA TIBBI MALZEMENAYI VE TICARET AS Business Description
MEDITERA TIBBI MALZEME SANAYI VE TICARET AS is engaged in the manufacture of anesthesia and intensive care circuits, the installation, operation, and design of oncology drug preparation and delivery systems, production, sales, and technical service of infusion pumps and sets, and the manufacture of biocidal products.
79GF Score
Get the complete analysis for IST:MEDTR
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IST:MEDTR has been successfully added to your 
